kvan1917, I think the article indicates that the DMS molecule is a byproduct of nerve sheathe growth -- like smoke is a product of fire, I suppose.

For us, perhaps what the study leads toward might be therapies aimed at managing the byproduct in such a way that it reduces or eliminates the neuropathic pain it causes. Like using a woodstove but managing the smoke so it doesn't choke you.

A better metaphor might be the soreness one gets after exercising hard. The muscles are growing but during the process they tend to hurt a bit. If we could have the growth without the hurt it would be better...!

That's where I think the DMS - neuropathic pain link is. The DMS doesn't help nerves grow, but it's a product of increased nerve growth. And it causes pain. So if we could have the regrowth without the pain -- by blocking the effects of the DMS -- then it may ease neuropathic symptoms? Maybe?